World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21430
World Ranking
15282
National Ranking
7710

Overview

George Sgouros is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on Medicine, with a substantial emphasis on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Radiation, Oncology, and Epidemiology. The scientist has contributed extensively to the advancement of knowledge in these fields through numerous scholarly publications.

Their recent papers include:

  • Radiopharmaceutical therapy in cancer: clinical advances and challenges, 2020, Nature Reviews Drug Discovery
  • ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy, 2021, Journal of the ICRU

Frequent co-authors collaborating with George Sgouros include:

  • Robert F. Hobbs
  • Eric C. Frey
  • Wesley E. Bolch
  • Ioanna Liatsou
  • Jing Yu

Publication venues where George Sgouros has contributed significantly include:

  • Journal of Nuclear Medicine
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • Physics in Medicine and Biology
  • Nature Reviews Drug Discovery

The main fields of study addressed in their work are:

  • Medicine

Subfields of study investigated by George Sgouros include:

  • Radiology, Nuclear Medicine and Imaging
  • Pulmonary and Respiratory Medicine
  • Radiation
  • Oncology
  • Epidemiology

Key topics covered in their research entail:

  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Lung Cancer Treatments and Mutations
  • Advanced Radiotherapy Techniques
  • Radiation Therapy and Dosimetry
  • Radiation Dose and Imaging
  • Prostate Cancer Treatment and Research

The scientist's work contributes to understanding radiopharmaceutical therapies in cancer, dosimetry-guided therapeutic approaches, and imaging techniques related to treatment and diagnostics. Collaborations with co-authors in radiation therapy and nuclear medicine indicate a multidisciplinary approach in their research activities.

Best Publications

  • MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature

    Wesley E. Bolch;Keith F. Eckerman;George Sgouros;Stephen R. Thomas

  • Targeted α particle immunotherapy for myeloid leukemia

    Joseph G. Jurcic;Steven M. Larson;Steven M. Larson;George Sgouros;George Sgouros;Michael R. McDevitt;Michael R. McDevitt

  • Radiopharmaceutical therapy in cancer: clinical advances and challenges.

    George Sgouros;Lisa Bodei;Michael R. McDevitt;Jessie R. Nedrow

  • Radioimmunotherapy with alpha-emitting nuclides

    Michael R. McDevitt;George Sgouros;Ronald D. Finn;John L. Humm

  • MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

    George Sgouros;John C. Roeske;Michael R. McDevitt;Stig Palm

  • Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

    Zsolt Szabo;Esther Mena;Steven P. Rowe;Donika Plyku

  • Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

    Weiping Wang;Steven M. Larson;Melissa Fazzari;Satish K. Tickoo

  • 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer

    Ying Chen;Mrudula Pullambhatla;Catherine Foss;Youngjoo Byun;Youngjoo Byun

  • MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy

    Yuni K. Dewaraja;Eric C. Frey;George Sgouros;A. Bertrand Brill

  • Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.

    George Sgouros

  • Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

    Steve Y. Cho;Kenneth L. Gage;Ronnie C. Mease;Srinivasan Senthamizhchelvan

  • Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.

    George Sgouros;George Sgouros;Katherine S. Kolbert;Arif Sheikh;Keith S. Pentlow

  • An α-Particle Emitting Antibody ([213Bi]J591) for Radioimmunotherapy of Prostate Cancer

    Michael R. McDevitt;Els Barendswaard;Dangshe Ma;Lawrence Lai

  • N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer

    Ronnie C. Mease;Crystal L. Dusich;Catherine A. Foss;Hayden T. Ravert

  • MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications

    Yuni K. Dewaraja;Michael Ljungberg;Alan J. Green;Pat B. Zanzonico

  • Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia

    Todd L. Rosenblat;Michael R. McDevitt;Deborah A. Mulford;Neeta Pandit-Taskar

  • Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia

    George Sgouros;Åse M. Ballangrud;Joseph G. Jurcic;Michael R. McDevitt

  • A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity

    PC Caron;JG Jurcic;AM Scott;RD Finn

  • MIRD pamphlet no. 20: The effect of model assumptions on kidney dosimetry and response - Implications for radionuclide therapy

    Barry W. Wessels;Mark W. Konijnenberg;Roger G. Dale;Hazel B. Breitz

  • Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.

    Chaitanya R. Divgi;Neil H. Bander;Neil H. Bander;Neil H. Bander;Andrew M. Scott;Andrew M. Scott;Joseph A. O'Donoghue

Frequent Co-Authors

Eric C. Frey
Eric C. Frey Johns Hopkins University
Richard L. Wahl
Richard L. Wahl Washington University in St. Louis
David A. Scheinberg
David A. Scheinberg Memorial Sloan Kettering Cancer Center
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Martin G. Pomper
Martin G. Pomper Johns Hopkins University School of Medicine
Andrew M. Scott
Andrew M. Scott La Trobe University
David L. Huso
David L. Huso Johns Hopkins University
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
David M. Goldenberg
David M. Goldenberg Immunomedics (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a wide range of online degrees and health-related career opportunities. Many students are now considering flexible online programs that lead to diverse roles within the healthcare system.

For those interested in pharmacy, there are online pharm d programs that enable students to pursue doctoral-level pharmacy credentials at their own pace. Similarly, the field of healthcare administration is growing, with options such as a health information technology online degree providing the skills needed to manage critical medical data.

Entry-level pathways like earning the cheapest medical coding certification online can quickly lead to jobs handling medical records and insurance claims. For advanced clinical practice, many pursue online nurse practitioner programs, which prepare nurses for leadership roles and direct patient care.

These online degrees and certifications offer alternative career pathways in medicine and healthcare, providing both affordability and convenience for students across the globe.

Best Scientists Citing George Sgouros

Trending Scientists